Rainmed Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	19.18	39.82	73.22	83.6	81.2
Revenue Growth (YoY)	-51.85%	-45.61%	-12.42%	2.96%	-
Cost of Revenue	10.14	15.96	24.67	13.78	12.17
Gross Profit	9.04	23.87	48.55	69.82	69.03
Selling, General & Admin	71.12	97.84	145.57	176.07	185.33
Research & Development	13.77	35.44	41.33	44.17	26.97
Other Operating Expenses	-3.44	-9.29	-6.69	-5.23	-0.43
Operating Expenses	81.45	124	180.21	215.01	211.87
Operating Income	-72.41	-100.13	-131.66	-145.19	-142.84
Interest Expense	-0.72	-0.94	-1.31	-0.76	-3.86
Interest & Investment Income	-	3.93	12.41	3.5	1.81
Currency Exchange Gain (Loss)	-	-0.66	1.08	2.02	0.07
Other Non Operating Income (Expenses)	0.5	-	-	-1,211	-493.87
EBT Excluding Unusual Items	-72.63	-97.79	-119.48	-1,351	-638.68
Impairment of Goodwill	-6.81	-5.78	-	-	-
Gain (Loss) on Sale of Investments	-	1.25	2.4	0	0.04
Gain (Loss) on Sale of Assets	-	-0.01	-0.01	-0.02	-0.04
Asset Writedown	-	-12.98	-	-	-
Pretax Income	-79.44	-115.3	-117.09	-1,351	-638.69
Income Tax Expense	-0.04	0.24	-0.02	-5.45	-5.04
Earnings From Continuing Operations	-79.41	-115.54	-117.07	-1,346	-633.65
Minority Interest in Earnings	2.32	2.05	1.24	-	0
Net Income	-77.08	-113.5	-115.83	-1,346	-633.65
Net Income to Common	-77.08	-113.5	-115.83	-1,346	-633.65
Shares Outstanding (Basic)	1,285	1,168	1,168	898	643
Shares Outstanding (Diluted)	1,285	1,168	1,168	898	643
Shares Change (YoY)	10.01%	-	30.01%	39.63%	-
EPS (Basic)	-0.06	-0.10	-0.10	-1.50	-0.99
EPS (Diluted)	-0.06	-0.10	-0.10	-1.50	-0.99
Free Cash Flow	-	-128.5	-208.97	-128.33	-103.67
Free Cash Flow Per Share	-	-0.11	-0.18	-0.14	-0.16
Gross Margin	47.14%	59.93%	66.31%	83.52%	85.02%
Operating Margin	-377.60%	-251.43%	-179.81%	-173.66%	-175.91%
Profit Margin	-401.98%	-284.99%	-158.20%	-1609.93%	-780.36%
Free Cash Flow Margin	-	-322.68%	-285.40%	-153.50%	-127.67%
EBITDA	-54.3	-82.02	-115.1	-134.39	-136.74
EBITDA Margin	-283.14%	-205.94%	-157.20%	-160.74%	-168.40%
D&A For EBITDA	18.11	18.11	16.56	10.8	6.1
EBIT	-72.41	-100.13	-131.66	-145.19	-142.84
EBIT Margin	-	-251.43%	-179.81%	-173.66%	-175.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.